Diagnostic pathways and delay among tuberculosis patients in Stockholm, Sweden: a retrospective observational study by Anna Wikell, Helena Åberg, Jad Shedrawy, Isac Röhl, Jerker Jonsson, Ingela Berggren, Charlotte Buxbaum, Knut Lönnroth, Judith Bruchfeld

Connect to this object online.

Population pharmacokinetics and dose evaluations of linezolid in the treatment of multidrug-resistant tuberculosis by Haoyue Zhang, Yuying He, Lina Davies Forsman, Lina Davies Forsman, Jakob Paues, Jakob Paues, Jim Werngren, Katarina Niward, Katarina Niward, Thomas Schön, Thomas Schön, Thomas Schön, Judith Bruchfeld, Judith Bruchfeld, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Yi Hu

Connect to this object online.

Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients by Ge Shao, Ziwei Bao, Lina Davies Forsman, Lina Davies Forsman, Jakob Paues, Jakob Paues, Jim Werngren, Katarina Niward, Katarina Niward, Thomas Schön, Thomas Schön, Thomas Schön, Judith Bruchfeld, Judith Bruchfeld, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Jan-Willem Alffenaar, Yi Hu

Connect to this object online.

Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study by Xu-Bin Zheng, Vinod K. Diwan, Qi Zhao, Yi Hu, Judith Bruchfeld, Wei-Li Jiang, Sven Hoffner, Biao Xu

Connect to this object online.

Drug Exposure and Susceptibility of Pyrazinamide Correlate with Treatment Response in Pyrazinamide-Susceptible Patients with Multidrug-Resistant Tuberculosis by Shulan Dong, Ge Shao, Lina Davies Forsman, Sainan Wang, Shanshan Wang, Jiayi Cao, Ziwei Bao, Judith Bruchfeld, Jan-Willem C. Alffenaar, Jia Liu, Yi Hu, Meiying Wu

Connect to this object online.